AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2018

Nov 7, 2018

29819_dirs_2018-11-06_ef04dd0b-d615-47c9-b3b9-c20eaeb30187.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2018-11-02

Reporting Person: Gordon Murdo (EVP Global Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-02	Common Stock	A	34213	—	Acquired	34213	Direct

Footnotes

F1: The Restricted Stock Units were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 35%, 35% and 30% on 11/2/2019, 11/2/2020 and 11/2/2021, respectively.